Bowhead Specialty (NYSE:BOW) Stock Price Expected to Rise, Morgan Stanley Analyst Says

Bowhead Specialty (NYSE:BOWGet Free Report) had its price target hoisted by equities research analysts at Morgan Stanley from $30.00 to $34.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Morgan Stanley’s price objective would indicate a potential upside of 1.57% from the company’s current price.

Several other analysts also recently issued reports on the company. Weiss Ratings upgraded Bowhead Specialty from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 23rd. UBS Group set a $28.00 price objective on Bowhead Specialty in a research report on Thursday, May 21st. Piper Sandler downgraded Bowhead Specialty from an “overweight” rating to a “hold” rating and set a $34.00 target price for the company. in a report on Monday, August 3rd. JPMorgan Chase & Co. boosted their target price on shares of Bowhead Specialty from $30.00 to $33.00 and gave the company a “neutral” rating in a research report on Monday, July 20th. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of Bowhead Specialty from a “buy” rating to a “hold” rating and set a $34.00 price target on the stock. in a research note on Monday, August 3rd. Two equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat.com, Bowhead Specialty presently has a consensus rating of “Hold” and an average price target of $33.50.

Read Our Latest Analysis on BOW

Bowhead Specialty Trading Up 0.1%

Shares of BOW stock opened at $33.48 on Wednesday. Bowhead Specialty has a 12-month low of $21.21 and a 12-month high of $35.07. The company has a market capitalization of $1.10 billion, a PE ratio of 18.09, a price-to-earnings-growth ratio of 1.00 and a beta of -0.11. The firm has a 50 day moving average price of $30.76 and a two-hundred day moving average price of $26.82. The company has a quick ratio of 0.49, a current ratio of 0.49 and a debt-to-equity ratio of 0.31.

Bowhead Specialty (NYSE:BOWGet Free Report) last posted its earnings results on Monday, August 3rd. The company reported $0.48 EPS for the quarter, beating the consensus estimate of $0.47 by $0.01. The company had revenue of $163.86 million for the quarter, compared to the consensus estimate of $278.69 million. Bowhead Specialty had a return on equity of 14.05% and a net margin of 10.11%. As a group, analysts predict that Bowhead Specialty will post 1.99 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of BOW. Langdon Equity Partners bought a new stake in Bowhead Specialty during the fourth quarter worth about $28,000. Versant Capital Management Inc increased its holdings in Bowhead Specialty by 262.6% in the 2nd quarter. Versant Capital Management Inc now owns 1,037 shares of the company’s stock valued at $31,000 after buying an additional 751 shares during the period. Parallel Advisors LLC increased its holdings in Bowhead Specialty by 181.4% in the 1st quarter. Parallel Advisors LLC now owns 1,652 shares of the company’s stock valued at $37,000 after buying an additional 1,065 shares during the period. CWM LLC raised its position in shares of Bowhead Specialty by 257.7% in the 4th quarter. CWM LLC now owns 1,481 shares of the company’s stock valued at $42,000 after buying an additional 1,067 shares in the last quarter. Finally, Raymond James Financial Inc. acquired a new position in shares of Bowhead Specialty in the 2nd quarter valued at approximately $52,000.

Bowhead Specialty Company Profile

(Get Free Report)

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.

Featured Articles

Analyst Recommendations for Bowhead Specialty (NYSE:BOW)

Receive News & Ratings for Bowhead Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bowhead Specialty and related companies with MarketBeat.com's FREE daily email newsletter.